Search research articles
Contact Us
Filters
Showing results (141-150 of 162) with videos related to
Page
of 17
Sort By:
Journal of Hepatology
|
February 13, 2017
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
Jose Luis Calleja, Javier Crespo, Diego Rincón, et al.
The American Journal of Gastroenterology
|
January 31, 2023
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)
Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Hepatology (Baltimore, Md.)
|
February 8, 2017
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry
Carlos Fernández Carrillo, Sabela Lens, Elba Llop, et al.
Revista Espanola De Enfermedades Digestivas
|
December 14, 2022
Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver
Joaquín Cabezas, Javier Crespo, Antonio Aguilera, et al.
Hepatology (Baltimore, Md.)
|
July 30, 2024
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure
Georg Semmler, Sonia Alonso López, Monica Pons, et al.
Journal of Hepatology
|
January 8, 2025
Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study)
Edo J Dongelmans, Grishma Hirode, Bettina E Hansen, et al.
Hepatology (Baltimore, Md.)
|
January 16, 2025
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure
Georg Semmler, Sonia Alonso López, Monica Pons, et al.
Journal of Hepatology
|
September 5, 2022
Non-invasive tests for clinically significant portal hypertension after HCV cure
Georg Semmler, Sabela Lens, Elias L Meyer, et al.
Journal of Hepatology
|
June 17, 2019
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs
Jordi Llaneras, Mar Riveiro-Barciela, Sabela Lens, et al.
Journal of Hepatology
|
March 23, 2024
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
Georg Semmler, Sonia Alonso López, Monica Pons, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 162) with videos related to
Sort By:
Page
of 17
Journal of Hepatology
|
February 13, 2017
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
Jose Luis Calleja, Javier Crespo, Diego Rincón, et al.
The American Journal of Gastroenterology
|
January 31, 2023
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)
Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Hepatology (Baltimore, Md.)
|
February 8, 2017
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry
Carlos Fernández Carrillo, Sabela Lens, Elba Llop, et al.
Revista Espanola De Enfermedades Digestivas
|
December 14, 2022
Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver
Joaquín Cabezas, Javier Crespo, Antonio Aguilera, et al.
Hepatology (Baltimore, Md.)
|
July 30, 2024
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure
Georg Semmler, Sonia Alonso López, Monica Pons, et al.
Journal of Hepatology
|
January 8, 2025
Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study)
Edo J Dongelmans, Grishma Hirode, Bettina E Hansen, et al.
Hepatology (Baltimore, Md.)
|
January 16, 2025
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure
Georg Semmler, Sonia Alonso López, Monica Pons, et al.
Journal of Hepatology
|
September 5, 2022
Non-invasive tests for clinically significant portal hypertension after HCV cure
Georg Semmler, Sabela Lens, Elias L Meyer, et al.
Journal of Hepatology
|
June 17, 2019
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs
Jordi Llaneras, Mar Riveiro-Barciela, Sabela Lens, et al.
Journal of Hepatology
|
March 23, 2024
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
Georg Semmler, Sonia Alonso López, Monica Pons, et al.
Page
of 17